147 related articles for article (PubMed ID: 12837544)
1. Synthesis and biological assessment of simplified analogues of the potent microtubule stabilizer (+)-discodermolide.
Mínguez JM; Kim SY; Giuliano KA; Balachandran R; Madiraju C; Day BW; Curran DP
Bioorg Med Chem; 2003 Jul; 11(15):3335-57. PubMed ID: 12837544
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and high content cell-based profiling of simplified analogues of the microtubule stabilizer (+)-discodermolide.
Minguez JM; Giuliano KA; Balachandran R; Madiraju C; Curran DP; Day BW
Mol Cancer Ther; 2002 Dec; 1(14):1305-13. PubMed ID: 12516963
[TBL] [Abstract][Full Text] [Related]
3. Total synthesis of the potent microtubule-stabilizing agent (+)-discodermolide.
Harried SS; Lee CP; Yang G; Lee TI; Myles DC
J Org Chem; 2003 Aug; 68(17):6646-60. PubMed ID: 12919029
[TBL] [Abstract][Full Text] [Related]
4. Simplified discodermolide analogues: synthesis and biological evaluation of 4-epi-7-dehydroxy-14,16-didemethyl-(+)-discodermolides as microtubule-stabilizing agents.
Choy N; Shin Y; Nguyen PQ; Curran DP; Balachandran R; Madiraju C; Day BW
J Med Chem; 2003 Jul; 46(14):2846-64. PubMed ID: 12825928
[TBL] [Abstract][Full Text] [Related]
5. A photoaffinity analogue of discodermolide specifically labels a peptide in beta-tubulin.
Xia S; Kenesky CS; Rucker PV; Smith AB; Orr GA; Horwitz SB
Biochemistry; 2006 Oct; 45(39):11762-75. PubMed ID: 17002277
[TBL] [Abstract][Full Text] [Related]
6. Synthetic analogues of the microtubule-stabilizing agent (+)-discodermolide: preparation and biological activity.
Gunasekera SP; Mickel SJ; Daeffler R; Niederer D; Wright AE; Linley P; Pitts T
J Nat Prod; 2004 May; 67(5):749-56. PubMed ID: 15165132
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of carbamate-substituted analogues of (+)-discodermolide.
Smith AB; Freeze BS; Lamarche MJ; Hirose T; Brouard I; Rucker PV; Xian M; Sundermann KF; Shaw SJ; Burlingame MA; Horwitz SB; Myles DC
Org Lett; 2005 Jan; 7(2):311-4. PubMed ID: 15646985
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and cytotoxicity of 7-deoxy aryl discodermolide analogues.
Burlingame MA; Shaw SJ; Sundermann KF; Zhang D; Petryka J; Mendoza E; Liu F; Myles DC; LaMarche MJ; Hirose T; Scott Freeze B; Smith AB
Bioorg Med Chem Lett; 2004 May; 14(9):2335-8. PubMed ID: 15081036
[TBL] [Abstract][Full Text] [Related]
9. Toward understanding how the lactone moiety of discodermolide affects activity.
Shaw SJ; Sundermann KF; Burlingame MA; Myles DC; Freeze BS; Xian M; Brouard I; Smith AB
J Am Chem Soc; 2005 May; 127(18):6532-3. PubMed ID: 15869264
[TBL] [Abstract][Full Text] [Related]
10. Distinct pose of discodermolide in taxol binding pocket drives a complementary mode of microtubule stabilization.
Khrapunovich-Baine M; Menon V; Verdier-Pinard P; Smith AB; Angeletti RH; Fiser A; Horwitz SB; Xiao H
Biochemistry; 2009 Dec; 48(49):11664-77. PubMed ID: 19863156
[TBL] [Abstract][Full Text] [Related]
11. Discodermolide analogues as the chemical component of combination bacteriolytic therapy.
Smith AB; Freeze BS; LaMarche MJ; Sager J; Kinzler KW; Vogelstein B
Bioorg Med Chem Lett; 2005 Aug; 15(15):3623-6. PubMed ID: 15979874
[TBL] [Abstract][Full Text] [Related]
12. Total synthesis and biological evaluation of a series of macrocyclic hybrids and analogues of the antimitotic natural products dictyostatin, discodermolide, and taxol.
Paterson I; Naylor GJ; Gardner NM; Guzmán E; Wright AE
Chem Asian J; 2011 Feb; 6(2):459-73. PubMed ID: 21254424
[TBL] [Abstract][Full Text] [Related]
13. The structure activity relationship of discodermolide analogues.
Shaw SJ
Mini Rev Med Chem; 2008 Mar; 8(3):276-84. PubMed ID: 18336347
[TBL] [Abstract][Full Text] [Related]
14. Conception, synthesis, and biological evaluation of original discodermolide analogues.
de Lemos E; Agouridas E; Sorin G; Guerreiro A; Commerçon A; Pancrazi A; Betzer JF; Lannou MI; Ardisson J
Chemistry; 2011 Aug; 17(36):10123-34. PubMed ID: 21793059
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of simplified analogues of (+)-discodermolide. Additional insights on the importance of the diene, the C7 hydroxyl, and the lactone.
Smith AB; Xian M
Org Lett; 2005 Nov; 7(23):5229-32. PubMed ID: 16268545
[TBL] [Abstract][Full Text] [Related]
16. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.
Honore S; Kamath K; Braguer D; Horwitz SB; Wilson L; Briand C; Jordan MA
Cancer Res; 2004 Jul; 64(14):4957-64. PubMed ID: 15256469
[TBL] [Abstract][Full Text] [Related]
17. Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation.
Honore S; Kamath K; Braguer D; Wilson L; Briand C; Jordan MA
Mol Cancer Ther; 2003 Dec; 2(12):1303-11. PubMed ID: 14707271
[TBL] [Abstract][Full Text] [Related]
18. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.
Madiraju C; Edler MC; Hamel E; Raccor BS; Balachandran R; Zhu G; Giuliano KA; Vogt A; Shin Y; Fournier JH; Fukui Y; Brückner AM; Curran DP; Day BW
Biochemistry; 2005 Nov; 44(45):15053-63. PubMed ID: 16274252
[TBL] [Abstract][Full Text] [Related]
19. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.
Kowalski RJ; Giannakakou P; Gunasekera SP; Longley RE; Day BW; Hamel E
Mol Pharmacol; 1997 Oct; 52(4):613-22. PubMed ID: 9380024
[TBL] [Abstract][Full Text] [Related]
20. The clinical development of new mitotic inhibitors that stabilize the microtubule.
Mani S; Macapinlac M; Goel S; Verdier-Pinard D; Fojo T; Rothenberg M; Colevas D
Anticancer Drugs; 2004 Jul; 15(6):553-8. PubMed ID: 15205596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
